TEMIXYS
LIVE

Serial Number

79229584

Owner

CELLTRION, INC.

Attorney

Kisuk Lee

Filing Date

Feb 1, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TEMIXYS Trademark

Serial Number: 79229584 • Registration: 5652077

TEMIXYS is a trademark filed by CELLTRION, INC. on February 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

CELLTRION, INC. (115 trademarks)

23, Academy-ro,

Entity Type: 03

Trademark Details

Filing Date

February 1, 2018

Registration Date

January 15, 2019

Published for Opposition

October 30, 2018

Cancellation Date

August 1, 2025

Goods & Services

Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overload, migraine and diabetes; medicines for the treatment of cardiac, neurologic, metabolic, genetic, psychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugs, namely, anti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticals, namely, pharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticals, namely, pharmaceutical preparations for the treatment of HIV/AIDS

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 1, 2026 INTR
CANCELLED SECTION 71
Aug 1, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 15, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 5, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 25, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 4, 2019 FICS
FINAL DISPOSITION PROCESSED
May 4, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 15, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 15, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 30, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 30, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Oct 26, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 10, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 10, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 10, 2018 NONP
ASSIGNED TO LIE
Sep 17, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 5, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2018 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 22, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2018 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2018 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2018 TROA
REFUSAL PROCESSED BY IB
Jun 8, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 21, 2018 RFCS
REFUSAL PROCESSED BY MPU
May 21, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 16, 2018 RFCR
NON-FINAL ACTION WRITTEN
May 15, 2018 CNRT
ASSIGNED TO EXAMINER
May 15, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 10, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 6, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 5, 2018 REPR